Search Bar & Filters
Found 1 Actively Recruiting clinical trials
Actively Recruiting
Researchers are studying whether ultrasound-guided alcohol sclerotherapy can reduce pelvic pain and improve quality of life in women aged 18 to 45 diagnosed with ovarian endometriomas, compared to expectant management. Endometriosis is a common condition causing chronic pelvic pain and fertility issues, with ovarian endometrioma being the most frequent form. This trial aims to clarify if sclerotherapy offers better symptom relief and quality of life improvements than simply monitoring the condition. Participants will be randomly assigned to either receive ultrasound-guided alcohol sclerotherapy, where the cyst is punctured and treated with alcohol for 15 minutes followed by a wash, or to a control group receiving expectant management with standard pain care if needed. The study will compare these groups over 6 months, focusing on pain levels, quality of life, and fertility outcomes. During the study, participants will complete pain and quality of life assessments at the start and after 6 months. They will also provide blood and urine samples for biomarker analysis and undergo tests to assess ovarian reserve. Researchers will monitor adverse events, recurrence, pregnancy rates over about 2 years, and healthcare costs. The study uses rigorous analysis methods to assess the benefits and risks of the treatment.